Our recent studies demonstrating that ARF1 is involved in the activation of the MAPK ERK1/2 pathway which has been implicated in the progression of prostate cancer prompt us to define the possible function of ARF1 in prostate cancer. This evidence concerns the gene ARF1 and prostate carcinoma.